(18)F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports.

[1]  N. Galldiks,et al.  From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors? , 2015, Neuro-oncology.

[2]  N. Shah,et al.  Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  Gereon R Fink,et al.  The Usefulness of Dynamic O-(2-18F-Fluoroethyl)-l-Tyrosine PET in the Clinical Evaluation of Brain Tumors in Children and Adolescents , 2015, The Journal of Nuclear Medicine.

[4]  I. Steffen,et al.  18F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors , 2015, Child's Nervous System.

[5]  Giles W. Robinson,et al.  Medulloblastoma—translating discoveries from the bench to the bedside , 2014, Nature Reviews Clinical Oncology.

[6]  M. Guenot,et al.  Accuracy of distinguishing between dysembryoplastic neuroepithelial tumors and other epileptogenic brain neoplasms with [¹¹C]methionine PET. , 2014, Neuro-oncology.

[7]  A. Buck,et al.  Comparison of the Amino Acid Tracers 18F-FET and 18F-DOPA in High-Grade Glioma Patients , 2014, The Journal of Nuclear Medicine.

[8]  S. Vajapeyam,et al.  18F-FDG PET and MR Imaging Associations Across a Spectrum of Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium , 2014, The Journal of Nuclear Medicine.

[9]  A. Piccardo,et al.  Value of 18F-3,4-Dihydroxyphenylalanine PET/MR Image Fusion in Pediatric Supratentorial Infiltrative Astrocytomas: A Prospective Pilot Study , 2014, The Journal of Nuclear Medicine.

[10]  K. Hoffmann,et al.  Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors , 2014, Child's Nervous System.

[11]  Gereon R Fink,et al.  Comparison of 18F-FET PET and Perfusion-Weighted MR Imaging: A PET/MR Imaging Hybrid Study in Patients with Brain Tumors , 2014, The Journal of Nuclear Medicine.

[12]  Francesco Scopinaro,et al.  Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  Gereon R Fink,et al.  Role of O-(2-18F-Fluoroethyl)-l-Tyrosine PET as a Diagnostic Tool for Detection of Malignant Progression in Patients with Low-Grade Glioma , 2013, The Journal of Nuclear Medicine.

[14]  Eugen Trinka,et al.  [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. , 2013, Neuro-oncology.

[15]  Stefan M. Pfister,et al.  The clinical implications of medulloblastoma subgroups , 2012, Nature Reviews Neurology.

[16]  J. Sarkaria,et al.  The role of LAT1 in 18F-DOPA uptake in malignant gliomas , 2012, Journal of Neuro-Oncology.

[17]  G. Garg,et al.  Demonstration of diffuse leptomeningeal metastasis in a treated case of medulloblastoma with F-18 FDG PET/CT. , 2009, Clinical nuclear medicine.

[18]  Karl-Josef Langen,et al.  O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. , 2006, Nuclear medicine and biology.

[19]  Karl Herholz,et al.  18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Joji Kawabe,et al.  Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas , 2005, Annals of nuclear medicine.

[21]  R. Coleman,et al.  [18F]Fluorodeoxyglucose-Positron Emission Tomography in Patients with Medulloblastoma , 2004, Neurosurgery.

[22]  E. Rushing,et al.  From the archives of the AFIP: medulloblastoma: a comprehensive review with radiologic-pathologic correlation. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[23]  K. Någren,et al.  Metabolic characterization of childhood brain tumors , 2002, Cancer.

[24]  D. Freudenstein,et al.  MRI features of primary, secondary and metastatic medulloblastoma , 2002, European Radiology.

[25]  F. Berthold,et al.  In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment , 1993, Cancer.

[26]  D. Bigner,et al.  Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma. , 1988, Cancer research.